ARTVNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Artiva Biotherapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$5.89+0.04 (+0.68%)
Close on Oct 19, 2026
- Market cap
- $232.14M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
33 of Artiva Biotherapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 8, 2026 | Sep 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 8, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 22, 2026 | Jul 22, 2026 | SEC EDGAR |
| Current report | 8-K | May 18, 2026 | May 19, 2026 | SEC EDGAR |
| Current report | 8-K | May 8, 2026 | May 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 8, 2026 | SEC EDGAR |
| Current report | 8-K | May 8, 2026 | May 8, 2026 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2025 | Apr 30, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 10, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2026 | Mar 10, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2026 | Feb 24, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2026 | Feb 19, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2025 | Dec 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2025 | Jun 25, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 24, 2025 | Apr 29, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2025 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 28, 2025 | Jan 29, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 21, 2024 | Oct 22, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 29, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 29, 2024 | Aug 29, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 22, 2024 | Jul 22, 2024 | SEC EDGAR |